Skip to content

Clinical trials

Completed Phase 3 Coronary Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Phase: Phase 3 Status: Completed Clear all

125 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20023
20039
20044
20055
20069
20075
20088
20097
20101
20115
20122
20131
20151
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed125

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)37
Organon and Co7
Abbott5
AstraZeneca5
University of Washington5
Abbott Medical Devices3
Brigham and Women's Hospital3
Hoffmann-La Roche3
Carelon Research2
Cordis US Corp.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease125
Cardiovascular Diseases66
Heart Diseases62
Myocardial Ischemia55
Myocardial Infarction26
Hypercholesterolemia20
Coronary Artery Disease18
Atherosclerosis11
Dyslipidemias11
Hypertension9

Trials

Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.

25 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.